Open access
Jul 2026
HPLC-MS Quantification of Multiple Tyrosine Kinase Inhibitors in Patients with Solid Tumors: Method Validation and Clinical Application
A reliable method to quantify several tyrosine kinase inhibitors from plasma and capillary blood, which is intended for TDM purposes in clinical practice is developed.
Juliane Staudinger, Marcel Kemper, Carolin Krekeler et al.
· Pharmaceutics · 0 citations